Middle East and Africa Biomedical Sensors Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Type; Sensor Type; Product; Application

The Middle East and Africa biomedical sensors market is expected to reach US$ 620.2 million by 2027 from US$ 379.1 million in 2019. The market is estimated to grow at a CAGR of 6.3% during 2020–2027.

The growth of the Middle East and Africa biomedical sensors market is attributed to the key driving factors such as the rising incidence of lifestyle-based diseases (CVD) and an increasing adoption of biomedical sensors. However, the security concerns regarding the use of biomedical sensors hinder the market growth.

Factors such as antimicrobial resistance, adoption of unhealthy lifestyles, consumption of alcohol, and smoking contribute to the rising prevalence of lifestyle-based diseases, such as diabetes. As per the International Diabetes Federation, in 2019, ~463 million adults had diabetes, and this number is expected to reach 700 million by 2045. Therefore, the demand for biomedical sensors is increasing for regular health monitoring. Moreover, cardiovascular diseases (CVD) pose a significant threat to human health and lead to a tremendous burden on developed and developing economies worldwide. According to the World Health Organization (WHO), CVD accounted for nearly 17.9 million deaths in 2018. This poses the need for patient monitoring devices to mitigate the death rate caused due to lifestyle-based diseases.

Additionally, rising number of geriatric population and increasing cases of obesity are the factors promoting the healthcare awareness among population. Various established players in the medical device industry have been investing a significant amount in R&D activities to develop better and advanced solutions to cater to the needs of their customers. With the regulations laid down by the government bodies, it is possible to obtain better and reliable health management solutions, ensuring quality care, patient safety, and disease management. For instance, the Centers for Disease Control and Prevention (CDC) leads efforts to control communicable and infectious disease outbreaks and promote immunization to the people. The federal government also aids states with funding and guidance for work such as emergency preparedness. Thus, the above factors drive the growth of the Middle East and Africa biomedical sensors market.

Countries such as Saudi Arabia and the UAE are highly affected due to COVID outbreak. According to the Worldometer data, as of March 1, 2021, South Africa reported more than 1.51 million COVID-19 positive cases. From December 2020, Iran reported the highest number of infections in the Middle East. Until May 19, 2020, the total positive cases in Brazil were 271,628. The increasing numbers of positive cases are becoming threats to respective countries. The countries are facing economic crises, which is affecting various businesses, including the healthcare business. Although, the biomedical sensors market is increasing with the rapid rise in COVID-19 detection tests. Therefore, various technologies have been developed for the rapid testing. For instance, some researchers at Alfaisal University in Riyadh collaborated with King Abdullah International Medical Research Center in Riyadh and developed biomedical sensors to detect Middle East respiratory syndrome coronavirus (MERS), and King Faisal Specialist Hospital and Research Centre partnered to test for other viruses. There has been ongoing research for smart masks to eradicate the outbreak from its roots with various technological advancements.

Based on type, the Middle East and Africa biomedical sensors market is bifurcated into wired and wireless. The wireless segment held a larger market share in 2019, also the same segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on sensor type, the Middle East and Africa biomedical sensors market is segmented into temperature, pressure, image sensors, biochemical, inertial sensors, motion sensors, electrocardiogram (ECG), and other sensor types. The temperature segment held the largest market share in 2019, whereas the motion sensors segment is anticipated to register the highest CAGR in the market during 2020–2027.

The Middle East and Africa biomedical sensors market, by product, is bifurcated into invasive sensors and non-invasive sensors. The non-invasive sensors segment held a larger market share in 2019, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on application, the Middle East and Africa biomedical sensors market is segmented into medical diagnostics, clinical therapy, imaging, and personal healthcare. The medical diagnostics segment held the largest market share in 2019, whereas the personal healthcare segment is anticipated to register the highest CAGR in the market during 2020–2027.

A few of the primary and secondary sources referred to while preparing the report on the Middle East and Africa biomedical sensors market are the International Diabetes Federation (IDF) and Saudi Arabian Monetary Agency (SAMA).

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Middle East and Africa biomedical sensors market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in the Middle East and Africa biomedical sensors market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth, offering developed and emerging markets.
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.